BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Renner B, Klawitter J, Goldberg R, McCullough JW, Ferreira VP, Cooper JE, Christians U, Thurman JM. Cyclosporine induces endothelial cell release of complement-activating microparticles. J Am Soc Nephrol. 2013;24:1849-1862. [PMID: 24092930 DOI: 10.1681/asn.2012111064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Blatt AZ, Pathan S, Ferreira VP. Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev 2016;274:172-90. [PMID: 27782331 DOI: 10.1111/imr.12466] [Cited by in Crossref: 64] [Cited by in F6Publishing: 48] [Article Influence: 12.8] [Reference Citation Analysis]
2 Stokman MF, Renkema KY, Giles RH, Schaefer F, Knoers NV, van Eerde AM. The expanding phenotypic spectra of kidney diseases: insights from genetic studies. Nat Rev Nephrol 2016;12:472-83. [PMID: 27374918 DOI: 10.1038/nrneph.2016.87] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
3 Kirkby NS, Chan MV, Zaiss AK, Garcia-Vaz E, Jiao J, Berglund LM, Verdu EF, Ahmetaj-Shala B, Wallace JL, Herschman HR, Gomez MF, Mitchell JA. Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways. Proc Natl Acad Sci U S A 2016;113:434-9. [PMID: 26712011 DOI: 10.1073/pnas.1517642113] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 14.0] [Reference Citation Analysis]
4 Luft T, Dreger P, Radujkovic A. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation. Bone Marrow Transplant 2021. [PMID: 34253879 DOI: 10.1038/s41409-021-01390-y] [Reference Citation Analysis]
5 Lo S, Jiang L, Stacks S, Lin H, Parajuli N. Aberrant activation of the complement system in renal grafts is mediated by cold storage. Am J Physiol Renal Physiol 2021;320:F1174-90. [PMID: 33998295 DOI: 10.1152/ajprenal.00670.2020] [Reference Citation Analysis]
6 Ponticelli C, Moroni G, Glassock RJ. De novo glomerular diseases after renal transplantation. Clin J Am Soc Nephrol. 2014;9:1479-1487. [PMID: 24700797 DOI: 10.2215/cjn.12571213] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
7 Tjon J, Teoh CW. Medication-Induced Nephrotoxicity in Children. Curr Pediatr Rep 2020;8:122-33. [DOI: 10.1007/s40124-020-00223-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ståhl AL, Johansson K, Mossberg M, Kahn R, Karpman D. Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. Pediatr Nephrol 2019;34:11-30. [PMID: 29181712 DOI: 10.1007/s00467-017-3816-z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 15.6] [Reference Citation Analysis]
9 Kielar M, Gala-Błądzińska A, Dumnicka P, Ceranowicz P, Kapusta M, Naumnik B, Kubiak G, Kuźniewski M, Kuśnierz-Cabala B. Complement Components in the Diagnosis and Treatment after Kidney Transplantation-Is There a Missing Link? Biomolecules 2021;11:773. [PMID: 34064132 DOI: 10.3390/biom11060773] [Reference Citation Analysis]
10 Ávila A, Gavela E, Sancho A. Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity. Front Med (Lausanne) 2021;8:642864. [PMID: 33898482 DOI: 10.3389/fmed.2021.642864] [Reference Citation Analysis]
11 Li NL, Birmingham DJ, Rovin BH. Expanding the Role of Complement Therapies: The Case for Lupus Nephritis. J Clin Med 2021;10:626. [PMID: 33562189 DOI: 10.3390/jcm10040626] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Atzeni F, Rodríguez-Carrio J, Popa CD, Nurmohamed MT, Szűcs G, Szekanecz Z. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat Rev Rheumatol 2021;17:270-90. [PMID: 33833437 DOI: 10.1038/s41584-021-00593-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Jeon H, Han SR, Lee S, Park SJ, Kim JH, Yoo SM, Lee MS. Activation of the complement system in an osteosarcoma cell line promotes angiogenesis through enhanced production of growth factors. Sci Rep 2018;8:5415. [PMID: 29615744 DOI: 10.1038/s41598-018-23851-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141 [PMID: 30211021 DOI: 10.5500/wjt.v8.i5.122] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
15 Román E, Mendizábal S, Jarque I, de la Rubia J, Sempere A, Morales E, Praga M, Ávila A, Górriz JL. Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option. Nefrología (English Edition) 2017;37:478-91. [DOI: 10.1016/j.nefroe.2017.08.001] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Deng F, Wang S, Zhang L. Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review. J Cell Mol Med 2017;21:1698-710. [PMID: 28316143 DOI: 10.1111/jcmm.13125] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
17 Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant 2017;32:466-74. [PMID: 28339660 DOI: 10.1093/ndt/gfw453] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 13.4] [Reference Citation Analysis]
18 Kirpalani A, Teoh CW, Ng VL, Dipchand AI, Matsuda-Abedini M. Kidney disease in children with heart or liver transplant. Pediatr Nephrol 2021. [PMID: 33599850 DOI: 10.1007/s00467-021-04949-5] [Reference Citation Analysis]
19 Goetz L, Laskowski J, Renner B, Pickering MC, Kulik L, Klawitter J, Stites E, Christians U, van der Vlag J, Ravichandran K, Holers VM, Thurman JM. Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM. Eur J Immunol 2018;48:791-802. [PMID: 29389016 DOI: 10.1002/eji.201747240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
20 Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, Christians U, Klawitter J, Lindorfer MA, Taylor RP, Holers VM, Thurman JM. Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease. J Am Heart Assoc 2018;7:e007818. [PMID: 30006493 DOI: 10.1161/JAHA.117.007818] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
21 Salih M, Demmers JA, Bezstarosti K, Leonhard WN, Losekoot M, van Kooten C, Gansevoort RT, Peters DJ, Zietse R, Hoorn EJ; DIPAK Consortium. Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease. J Am Soc Nephrol 2016;27:3079-92. [PMID: 26940098 DOI: 10.1681/ASN.2015090994] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
22 Sheen JH, Heeger PS. Effects of complement activation on allograft injury. Curr Opin Organ Transplant 2015;20:468-75. [PMID: 26132735 DOI: 10.1097/MOT.0000000000000216] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
23 Shamekhi Amiri F. Microparticles in kidney diseases: focus on kidney transplantation. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-017-0104-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Kidd L, Geddings J, Hisada Y, Sueda M, Concannon T, Nichols T, Merricks E, Mackman N. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia. J Vet Intern Med 2015;29:908-16. [PMID: 25871966 DOI: 10.1111/jvim.12583] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
25 Karpman D, Ståhl AL, Arvidsson I. Extracellular vesicles in renal disease. Nat Rev Nephrol 2017;13:545-62. [PMID: 28736435 DOI: 10.1038/nrneph.2017.98] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 23.2] [Reference Citation Analysis]
26 Thurman JM, Wong M, Renner B, Frazer-Abel A, Giclas PC, Joy MS, Jalal D, Radeva MK, Gassman J, Gipson DS, Kaskel F, Friedman A, Trachtman H. Complement Activation in Patients with Focal Segmental Glomerulosclerosis. PLoS One 2015;10:e0136558. [PMID: 26335102 DOI: 10.1371/journal.pone.0136558] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
27 Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol 2019;15:87-108. [PMID: 30607032 DOI: 10.1038/s41581-018-0098-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 34.7] [Reference Citation Analysis]
28 Meng H, Kou J, Ma R, Ding W, Kou Y, Cao M, Dong Z, Bi Y, Thatte HS, Shi J. Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation. Mol Med Rep 2017;16:8579-88. [PMID: 29039531 DOI: 10.3892/mmr.2017.7763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Gilbert JS, Gillham HE, Regal JF. Down but not out: an emerging role for the B-type endothelin receptor in placental ischemia-induced hypertension. Hypertension 2014;64:461-2. [PMID: 24914197 DOI: 10.1161/HYPERTENSIONAHA.114.03477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]